Financial Assets
Tyra Biosciences Reports $345 Million in Cash, Cash Equivalents and Marketable Securities for First Quarter 2026 – geneonline.com
Related Articles
Wayve launches $85m employee share sale in UK first
TransportDealsWayve launched an $85 million secondary share sale for employees today –...
Nomura focuses on global advisory and capital markets as investors watch Japan’s financial sector
Nomura Holdings Inc (ISIN JP3762800005) is one of Japan's best-known financial services...
What are tokenized stocks? Equities on-chain guide
Tokenized stocks put real equities on blockchains as tradable tokens, and in...
Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update
Planned Interim Futility Analysis from Pivotal Phase 2 ALPHA3 Trial Supports Cemacabtagene...
Leave a comment